FDA Inspection
Accra-Pac, Inc.Accra-Pac, Inc. – FDA Inspection, Apr 5, 2017
Record Details
This FDA Inspection record concerns Accra-Pac, Inc., with an inspection on April 5, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
- People
- Bei Y. He
- Emily J. Stoklosa (Issuing Officer)
View Company Profile
ID · c717e591-2184-4717-8e3f-c943f688dfe8
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1009786
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
3- 21 CFR 211.192Extent of discrepancy, failure investigations
- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Accra-Pac, Inc.
10| Date | Classification | Office | Project area |
|---|---|---|---|
| March 5, 2026 | Not classified | Detroit District Office | Drug Quality Assurance |
| September 2, 2022 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 5, 2021 | NAI | Center for Devices and Radiological Health | Postmarket Assurance: Devices |
| November 21, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 20, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Accra-Pac, Inc.
- FDA Inspection 1288190 - 2026-03-05
- FDA Inspection 1178990 - 2022-09-02
- FDA Inspection 1157187 - 2021-11-05
- FDA Inspection 904407 - 2014-11-21
- FDA Inspection 855917 - 2013-11-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.